• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    CG Oncology, Inc. - Common stock (NQ:CGON)

    63.68 -1.28 (-1.97%)
    Streaming Delayed Price Updated: 9:53 AM EDT, Mar 24, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 115,330
    Open 64.00
    Bid (Size) 63.29 (100)
    Ask (Size) 63.77 (200)
    Prev. Close 64.96
    Today's Range 62.80 - 64.39
    52wk Range 14.80 - 69.35
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    As Terns Stock Soars 1,400%, What Does One Fund's $5.2 Million Sale Signal to Investors? ↗
    This clinical-stage biotech develops therapies for NASH and obesity, advancing a pipeline of proprietary small-molecule drug candidates. 
    Via The Motley Fool
    News headline image
    This Biotech Stock Up 135% Just Faced a $44 Million Trim. Here's What Investors Should Know ↗
    This clinical-stage biotech develops bladder-sparing therapies for high-risk cancer patients, targeting unmet needs in oncology treatment. 
    Via The Motley Fool
    Topics Regulatory Compliance

    Performance

    YTD
    +52.4%
    +52.4%
    1 Month
    +9.2%
    +9.2%
    3 Month
    +58.9%
    +58.9%
    6 Month
    +71.9%
    +71.9%
    1 Year
    +123.2%
    +123.2%

    More News

    Read More
    News headline image
    ImmunityBio (IBRX) Shares Plummet Despite Piper Sandler Price Target Hike and 700% Revenue Growth
    Via MarketMinute
    Topics Earnings Economy
    News headline image
    CG Oncology Reports 2025 Year End Financial Results and Provides Business Updates
    From CG Oncology Inc.
    Via GlobeNewswire
    News headline image
    CG Oncology to Present at the TD Cowen 46th Annual Health Care Conference
    From CG Oncology Inc.
    Via GlobeNewswire
    News headline image
    CG Oncology Soars 102% in a Year, but One Investor Just Disclosed a $58.5 Million Sale ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    ASCO GU 2026: Merck and Protara Poised to Disrupt Bladder and Kidney Cancer Standards
    Via MarketMinute
    Topics Intellectual Property
    What's going on in today's session ↗
    Via Chartmill
    Keep an eye on the top gainers and losers in Friday's session. ↗
    Via Chartmill
    News headline image
    CG Oncology Provides Updated Timeline for PIVOT-006 Phase 3 Topline Data in Intermediate-Risk NMIBC
    From CG Oncology Inc.
    Via GlobeNewswire
    News headline image
    CG Oncology to Present at the 44th Annual J.P. Morgan Healthcare Conference
    From CG Oncology Inc.
    Via GlobeNewswire
    News headline image
    This Biotech Fund Exited an $8 Million Edgewise Stake as the Stock Slid Double Digits ↗
    Via The Motley Fool
    News headline image
    SUO-CTC and CG Oncology Announce the Second Annual Non-Muscle Invasive Bladder Cancer (NMIBC) Research Fellowship Award
    From CG Oncology Inc.
    Via GlobeNewswire
    News headline image
    New Cretostimogene Grenadenorepvec Data Highlight its Potential to Become the Backbone Therapy for High-Risk Non-Muscle Invasive Bladder Cancer
    From CG Oncology Inc.
    Via GlobeNewswire
    News headline image
    Up 44% Since IPO: Why a Major Fund Just Made a $45 Million Bet on This Digital Health Stock ↗
    Via The Motley Fool
    Topics Initial Public Offering Regulatory Compliance
    News headline image
    Acadia Stock Up 59% in a Year — Is a $51 Million New Stake a Bet on a Bigger Rebound? ↗
    Via The Motley Fool
    News headline image
    Soleno Turns First Profit on $66 Million in Revenue — Is This Why One Investor Just Made an $87 Million Bet? ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    CG Oncology Announces New Board Member and Board Transition
    From CG Oncology Inc.
    Via GlobeNewswire
    News headline image
    CG Oncology to Present Results on Cretostimogene Grenadenorepvec at the Society of Urologic Oncology (SUO) 26th Annual Meeting
    From CG Oncology Inc.
    Via GlobeNewswire
    News headline image
    This Biotech Fund Has an $85 Million Bet on Amylyx as Stock Surges 180% and Co-CEOs Tease 'Transformational' Year Ahead ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    This Biotech Fund Made a New $40 Million Bet on Liquidia Amid Blockbuster Commercial Drug Launch ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Centessa Stock Has Surged 77% Over the Past Year — But a Top Biotech Fund Is Still Buying ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    This Fund Sold $49 Million of Cidara Stock — Then Merck Announced a $9.2 Billion Takeover ↗
    Via The Motley Fool
    News headline image
    CG Oncology Reports Third Quarter 2025 Financial Results and Provides Business Updates
    From CG Oncology Inc.
    Via GlobeNewswire
    News headline image
    Why Cg Oncology Stock Rocketed 7% Higher Today ↗
    Via The Motley Fool

    Frequently Asked Questions

    Is CG Oncology, Inc. - Common stock publicly traded?
    Yes, CG Oncology, Inc. - Common stock is publicly traded.
    What exchange does CG Oncology, Inc. - Common stock trade on?
    CG Oncology, Inc. - Common stock trades on the Nasdaq Stock Market
    What is the ticker symbol for CG Oncology, Inc. - Common stock?
    The ticker symbol for CG Oncology, Inc. - Common stock is CGON on the Nasdaq Stock Market
    What is the current price of CG Oncology, Inc. - Common stock?
    The current price of CG Oncology, Inc. - Common stock is 63.68
    When was CG Oncology, Inc. - Common stock last traded?
    The last trade of CG Oncology, Inc. - Common stock was at 03/24/26 09:53 AM ET
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.